Alnylam Pharmaceuticals, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts

Insiders trading volume in the past year

Alnylam Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Maraganore Chief Executive Officer, Director $42.8M Dec 21, 2021
Phillip A. Sharp Director $41.8M -$4.54M -9.8% May 16, 2024
Yvonne Greenstreet Chief Executive Officer, Director $22.5M -$13.6M -37.5% Aug 20, 2024
Jeffrey V. Poulton EVP, Chief Financial Officer $7.41M -$609K -7.59% Jun 24, 2024
D. E. I. Pyott Director $6.59M -$7.16M -52.1% Jun 24, 2024
Pushkal Garg CMO & EVP Dev & Med Affairs $4.43M -$769K -14.8% Jun 24, 2024
Akshay Vaishnaw President $4.32M Aug 3, 2023
Michael W. Bonney Director $3.75M -$5.85M -60.9% May 16, 2024
Kevin Fitzgerald CSO & EVP, Head of Research $3.69M -$6.25M -62.9% Aug 12, 2024
Tolga Tanguler EVP, Chief Commercial Officer $3.27M -$598K -15.5% Jun 24, 2024
Amy Schulman Director $2.02M -$5.26M -72.2% Jun 25, 2024
Laurie Keating EVP, Chief Legal Officer $1.03M Aug 5, 2021
Dennis A. Ausiello Director $969K -$5.31M -84.6% Aug 6, 2024
Indrani Franchini EVP, CLO & Secretary $915K -$323K -26.1% Feb 27, 2024
Steven M. Paul Director $185K Apr 1, 2022
Marsha Fanucci Director May 18, 2023
Peter N. Kellogg Director May 16, 2024
Margaret A. Hamburg Director May 16, 2024
Olivier Brandicourt Director May 16, 2024
Charles Elliott Sigal Director May 16, 2024
Colleen F. Reitan Director May 16, 2024
Carolyn R. Bertozzi Director May 16, 2024

Recent Insider Transactions by Companies or Individuals for Alnylam Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.